Who Can Legally Operate
Because the Harris Rider blocks the District from licensing or taxing recreational sales, there is no adult-use retailer license category at all — every legal cannabis business in D.C. operates under an ABCA medical cannabis license and may sell only to registered patients (D.C. resident or visiting). The widely known "I-71 gifting" storefront model — where a shop sold an unrelated item (art, stickers, t-shirts) at a markup and "gifted" cannabis alongside it — operated in a legal gray zone for years but was the target of a major 2024-2025 ABCA enforcement crackdown: more than 33 unlicensed shops were shut down outright and roughly 24 more closed after receiving warnings, with remaining unlicensed operators facing fines, closure orders, or criminal referral.
| Category | What You Can Do |
|---|---|
| Cultivation Center | Grow cannabis and sell to other licensed facilities (not direct to patients) |
| Manufacturer | Process flower into edibles, concentrates, and infused products; sell to other licensees |
| Retailer ("dispensary") | Retail sale to registered medical patients only |
| Internet Retailer / Courier | Online ordering and delivery to registered patients |
| Testing Laboratory | Independent potency and contaminant testing |
ABCA, "Medical Cannabis Business Licenses"; WUSA9, "Unlicensed cannabis gifting shops subject to penalties with new DC law"; Outlaw Report, "ABCA Clarifies Medical Cannabis Rules in Washington, D.C." — Verified June 17, 2026.
License Application & Fees
ABCA charges separate application and approval fees, with a substantially reduced combined fee for approved social equity applicants during their first three years of operation (Section 10).
| License / Fee Type | Amount |
|---|---|
| Conditional license — application fee (standard) | $800 |
| Conditional license — approval fee (standard) | $1,200 |
| Conditional license — total (standard) | $2,000 |
| Conditional license — total (social equity, yrs 1-3) | $500 ($200 + $300) |
| Standard Cultivation Center license — application/approval | $8,000 / $2,000 |
| Standard Manufacturer license — application/approval | $4,000 / $1,000 |
| Standard Retailer license — application/approval | Not clearly published in available sources — confirm current amount directly with ABCA |
ABCA, "Medical Cannabis Business License and Patient Fee Schedule" (abca.dc.gov) — Verified June 17, 2026. Retailer-specific standard fee amount not located in current public sources; confirm with ABCA before budgeting.
Ownership & Operating Rules
ABCA requires standard background and licensing review for all applicants and key personnel across every license category. Social equity applicants follow a distinct, more clearly documented pathway (Section 10) requiring a sworn declaration and supporting documentation rather than a separate ownership-percentage threshold of the kind several states impose.
| Requirement | Detail |
|---|---|
| Threshold | Must meet at least 2 of the listed criteria below |
| Income criterion | Household income not exceeding 150% of HUD-published median family income, adjusted for household size |
| Conviction-connection criterion | Applicant, spouse/civil union partner, child, parent, legal guardian, grandparent, or sibling has been arrested, convicted, or incarcerated for a cannabis or drug-related offense in D.C. or any other jurisdiction |
| Documentation | Social Equity Declaration Form plus a Social Equity Attestation Statement substantiating at least 2 criteria |
ABCA, "Medical Cannabis Social Equity Resource Guide" (PDF); ABCA, "Medical Cannabis - Social Equity Applicants" — Verified June 17, 2026.
What You Can Legally Sell
Licensed ABCA retailers may sell standard medical cannabis product categories to registered patients only — there is no legal commercial channel for selling cannabis to the general adult public in D.C. The only ways an adult without a medical registration can lawfully obtain cannabis are home cultivation or a true no-cost gift from another adult (Section 07); selling, or disguising a sale as a "gift" alongside a paid unrelated item, is illegal and an active enforcement target.
| Category | Status |
|---|---|
| Flower | Permitted — registered patients only |
| Concentrates / vape cartridges | Permitted — registered patients only |
| Edibles & infused products | Permitted — registered patients only; Mayor Bowser has proposed legislation to add locally produced cannabis beverages to the medical market in 2026 |
| Topicals & tinctures | Permitted — registered patients only |
| Any product sold to a non-patient adult for compensation | Not permitted under any license — no recreational retail channel exists |
ABCA, "Medical Cannabis Program"; Mayor Bowser press release, "Legislation to Diversify the Medical Cannabis Market with Local Beverage Partnerships" (2026) — Verified June 17, 2026.
Where You Can Operate
D.C. has no county- or municipal-level opt-out system the way states do — ABCA licensing and zoning apply uniformly citywide. The more consequential location risk in D.C. is unique to it: cannabis possession, use, cultivation, and gifting are illegal on any federally owned property — national parks, federal buildings, monuments, the National Mall, and other federal land scattered throughout the District — regardless of what D.C. law permits. Initiative 71 provides no protection on federal property, and a large share of D.C.'s most visible public space is federally owned.
DC Weed Events, "Federal Cannabis Policy In DC 2026: What Residents Must Know"; NORML, District of Columbia Laws and Penalties — Verified June 17, 2026.
Customer & Patient Rules
Initiative 71 allows an adult 21+ to gift up to 1 ounce of cannabis to another adult 21+, but only if absolutely no money, goods, or services change hands for the cannabis itself. The once-common commercial "gifting" storefront model — pay for an unrelated item, receive cannabis "free" — has been the subject of a sustained 2024-2025 ABCA crackdown and is treated as unlicensed distribution, not a lawful gift. A true gift between friends or family, with nothing exchanged, remains legal.
| Rule | Limit |
|---|---|
| Possession, adult 21+ | Up to 2 oz |
| Home cultivation, per adult | Up to 6 plants (3 mature) |
| Home cultivation, per household (multiple adults) | Capped at 12 plants total (6 mature), regardless of resident count |
| Cultivation conditions | Enclosed, not visible from public space without optical aids, odor mitigated, on the grower's own private property; no license, fee, or registration required |
| Gifting to another adult | Up to 1 oz, zero compensation of any kind |
| Medical patient purchase (registered) | Subject to ABCA per-patient purchase limits at licensed dispensaries |
| Cannabis on federal property | Prohibited regardless of D.C. law (Section 06) |
Triangle Hemp, "Washington DC Cannabis Home Grow Laws 2026"; Dr. Feelgood DC, "How I71 Gifting Works in Washington DC 2026 Update"; Weedmaps, "Washington, DC Medical Marijuana & Recreational Cannabis Info" — Verified June 17, 2026.
Tax Obligations
Medical dispensary sales currently carry a 6% D.C. sales tax. The Mayor's proposed FY2027 budget includes the Medical Cannabis Tax Rate Amendment Act of 2026, which would raise that rate to 10.25% — this is a proposal only, not yet enacted, and several D.C. Councilmembers and industry operators have publicly warned it could push consumers toward the illicit market. There is no recreational sales tax because no legal recreational retail market exists (Section 01, Harris Rider).
The DEA/DOJ's ~April 22, 2026 final order moved state-licensed medical marijuana programs to Schedule III federally, ending federal 280E disallowance for qualifying medical revenue. D.C. is not a state, and its medical program is licensed by a District agency (ABCA) rather than a state regulator. Whether the order's medical carve-out extends to D.C.-licensed medical cannabis businesses is an open interpretive question that available sources do not clearly resolve as of this report. D.C. cannabis businesses should consult a qualified tax professional before assuming federal 280E relief applies; no D.C.-specific 280E decoupling legislation was identified in available sources.
| Tax | Rate |
|---|---|
| Medical dispensary sales tax (current) | 6% |
| Medical dispensary sales tax (proposed FY2027) | 10.25% — not yet enacted |
| Recreational sales tax | N/A — no legal recreational retail market |
| D.C. 280E decoupling | Not identified in available sources |
| Federal 280E — medical revenue | Applicability of the ~Apr. 22, 2026 Schedule III carve-out to D.C.'s program is unconfirmed |
NORML, "District of Columbia Budget Proposal Calls for Significant Increase in Marijuana Sales Tax Rate" (Jun. 11, 2026); Washington City Paper, "D.C. Cannabis Operators Say a New Tax Could Push a Fragile Market Over the Edge"; ABCA, Medical Cannabis Sales Tax Holiday page — Verified June 17, 2026.
Ongoing Compliance Requirements
Retailers must verify a valid D.C. or visiting-patient registration card before every sale; D.C. residents 21+ can self-certify for a medical card without a doctor's visit.
Independent lab testing required for potency, pesticides, and contaminants before products reach dispensary shelves.
Child-resistant packaging and THC content disclosure required on all dispensary products.
ABCA's most recent emergency rulemaking on signs and advertising was adopted Feb. 5, 2025 and expired Jun. 5, 2025; confirm the current standing rule directly with ABCA (Section 13).
ABCA, "Patients—DC Residents"; ABCA, "2026 Medical Cannabis Rulemaking" — Verified June 17, 2026.
Social Equity Program 🔒
D.C.'s social equity program is built around a license set-aside rather than a points-based scoring system: at least 50% of all new Retailer licenses must be set aside for social equity applicants. To qualify, an applicant must meet at least 2 of the listed criteria — household income at or below 150% of HUD's median family income, or a personal or family connection (self, spouse/civil union partner, child, parent, legal guardian, grandparent, or sibling) to a cannabis- or drug-related arrest, conviction, or incarceration in any jurisdiction. Approved social equity licensees pay a combined conditional-license fee of just $500 versus $2,000 for standard applicants, and that 75% fee reduction on licensing fees carries through their first three years of operation.
| Mechanism | Detail |
|---|---|
| Retailer license set-aside | ≥50% of new Retailer licenses |
| Qualifying threshold | Meet at least 2 of the listed income/conviction-connection criteria |
| Fee reduction | 75% off licensing fees for the first 3 years |
| Documentation | Social Equity Declaration Form + Attestation Statement with supporting evidence |
ABCA, "Medical Cannabis Social Equity Resource Guide" (PDF); ABCA, "Licensed Operator, Social Equity Applicant Open Application Period" — Verified June 17, 2026.
Enforcement & Penalties 🔒
| Quantity / Circumstance | Classification | Penalty |
|---|---|---|
| Up to 2 oz, adult 21+ | Legal (within limit) | No penalty |
| More than 2 oz, intentional/knowing possession (non-patient) | Misdemeanor | Up to 6 months incarceration and/or up to $1,000 fine |
| Exchanging cannabis for money, goods, or services without a license | Felony (unlicensed distribution) | Up to 5 years imprisonment and/or up to $50,000 fine |
| Distribution near a school or involving a minor | Felony, enhanced | Penalties increase above the base distribution range |
| Disguised commercial "gifting" (paid item + free cannabis) | Treated as unlicensed sale/distribution | Fines, business closure, asset forfeiture, and/or criminal referral to the D.C. Attorney General |
| Possession/use/cultivation on federal property | Federal violation | Governed by federal law regardless of D.C. limits (Section 06) |
NORML, "District of Columbia Laws and Penalties"; WUSA9, "Unlicensed cannabis gifting shops subject to penalties with new DC law"; D.C. Code §48-904.01 — Verified June 17, 2026.
Employment Law Considerations
D.C.'s Cannabis Employment Protections Amendment Act gives most private-sector employees meaningful off-duty-use protection: an employer generally may not refuse to hire, terminate, suspend, fail to promote, demote, or otherwise penalize someone based solely on the presence of cannabinoid metabolites in an employer-requested drug test, without additional evidence of impairment. Impairment must be shown through specific, articulable symptoms that measurably decrease job performance or interfere with a safe workplace — a positive test alone is not enough. Exceptions apply where the employee is designated safety-sensitive, where a federal contract or statute requires testing or prohibits use, or where the employee used or possessed cannabis on the employer's premises or during work hours. D.C. government safety-sensitive employees face their own stricter standard: discipline for testing positive for any substance containing more than 0.03% THC.
| ✓ Permitted | ✗ Prohibited | ⚠ Gray Area |
|---|---|---|
| Testing and discipline for on-premises use, work-hours impairment, or safety-sensitive/federally mandated roles | Adverse action based solely on an off-duty positive THC metabolite test, absent other evidence of impairment | What specific facts satisfy the "articulable symptoms" impairment standard in borderline cases |
Jackson Lewis, "District of Columbia Cannabis Employment Protections Amendment Act Goes Live"; National Drug Screening, Washington, DC marijuana considerations — Verified June 17, 2026.
Advertising & Marketing Rules
ABCA's most recent emergency rulemaking specifically addressing signs and advertising was adopted February 5, 2025 and expired June 5, 2025. Available public sources do not clearly confirm what standing rule, if any, has since replaced it, and ABCA's "2026 Medical Cannabis Rulemaking" page indicates the rulemaking process remains active. Licensees should confirm current signage and advertising requirements directly with ABCA rather than relying on the 2025 emergency text, which has lapsed. General medical-marketing norms — restrictions on marketing to minors and a requirement to disclose licensee identity — are typical in this space but specific numeric thresholds (buffer distances, audience percentages) were not confirmed for D.C. in available sources.
ABCA, "2025 Medical Cannabis Rulemaking" and "2026 Medical Cannabis Rulemaking" pages (abca.dc.gov) — Verified June 17, 2026.
Resources & Contacts 🔒
| Office | Purpose | Contact |
|---|---|---|
| Alcoholic Beverage and Cannabis Administration (ABCA) | Licensing, patient registration, equity program, rulemaking | abca.dc.gov · (202) 442-4423 |
| D.C. Office of Tax and Revenue (OTR) | Medical cannabis sales tax remittance and reporting | otr.cfo.dc.gov |
| Metropolitan Police Department (MPD) | Possession/distribution enforcement, public-consumption violations | mpdc.dc.gov |
ABCA published contact directory — Verified June 17, 2026.
Recent & Upcoming Changes
This summary is provided for general informational purposes only and does not constitute legal, tax, or financial advice. Cannabis laws change frequently at the District and federal level, and D.C.'s relationship with Congress adds an additional layer of uncertainty not present in the states. Always confirm current requirements directly with ABCA, the D.C. Office of Tax and Revenue, or a licensed D.C. attorney before making business decisions. CannBus verifies sources at time of publication but cannot guarantee subsequent regulatory changes are reflected immediately.